Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Capital Employed (2016 - 2025)

Ani Pharmaceuticals' Return on Capital Employed history spans 14 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 10.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, up 10.0%, while the annual FY2025 figure was 0.1%, 10.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.1% at Ani Pharmaceuticals, up from 0.07% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.1% in Q4 2025 and bottomed at 0.09% in Q3 2022.
  • The 5-year median for Return on Capital Employed is 0.0% (2024), against an average of 0.0%.
  • The largest annual shift saw Return on Capital Employed dropped -8bps in 2022 before it increased 15bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.07% in 2021, then grew by 27bps to 0.05% in 2022, then soared by 215bps to 0.06% in 2023, then crashed by -99bps to 0.0% in 2024, then soared by 18015bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Return on Capital Employed are 0.1% (Q4 2025), 0.07% (Q3 2025), and 0.01% (Q2 2025).